欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/1208/001
药品名称Ranolazine Accord prolonged-release tablets 375 mg
活性成分
    • Ranolazine 375.0 mg
剂型Prolonged-release tablet
上市许可持有人Accord Healthcare Ireland Ltd., Euro House, Euro Business Park, Little Island, Cork T45 K857, Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Germany (DE)
      Ranolazin Accord 375 mg Retardtabletten
    • Austria (AT)
    • Italy (IT)
    • Latvia (LV)
    • Lithuania (LT)
      Ranolazine Accord 375 mg pailginto atpalaidavimo tabletės
    • Estonia (EE)
    • Cyprus (CY)
      Ranolazine Accord prolonged-release tablets 375 mg
    • Croatia (HR)
许可日期2024/04/30
最近更新日期2024/04/30
药物ATC编码
    • C01EB18 ranolazine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase